However, it seems prudent to advise added caution for patients taking semaglutide or those who are considering starting this medication if they have experienced visual loss from any cause. Reference: For more information: Cindy X
Inject slowly: Depress plunger steadily over 35 seconds to minimize discomfort
Another use of GLP-1RA is also under study in ELAD (121), a phase II b clinical trial to provide strong evidence in using GLP-1RA as neuroprotective agents against Alzheimers Disease
Mcclean PL, Parthsarathy V, Faivre E, Holscher C
The combination therapy of GLP-1 receptor agonists and metformin demonstrates superior safety over monotherapy, while revealing novel adverse events and demographic-specific risk patterns, thereby offering reliable evidence to inform clinical practice
At room temperature, degradation accelerates exponentially